(GSUS) Goldman Sachs MarketBeta US - Overview
Etf: Large-Cap, Mid-Cap, US Equity
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 1.91% |
| Yield CAGR 5y | 7.23% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.8% |
| Relative Tail Risk | 5.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -0.04 |
| Character TTM | |
|---|---|
| Beta | 0.967 |
| Beta Downside | 0.975 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.07% |
| CAGR/Max DD | 1.13 |
Description: GSUS Goldman Sachs MarketBeta US January 12, 2026
The Goldman Sachs MarketBeta US Equity ETF (GSUS) tracks an index that captures roughly the largest 85 % of the U.S. free-float market, focusing on large- and mid-cap stocks. By mandate, at least 80 % of the fund’s assets must be invested directly in the index constituents, their depositary receipts, or the underlying shares of those receipts.
Key quantitative points (as of the most recent public filing):
• Expense ratio ≈ 0.07 % – in line with other low-cost large-blend ETFs.
• Assets under management ≈ $1.2 bn, indicating modest scale but sufficient liquidity for most investors.
• 12-month total return (YTD) ≈ +9 %, driven largely by exposure to information technology (≈ 22 % of assets) and consumer discretionary (≈ 15 %).
These figures suggest the ETF offers broad market exposure at a competitive cost, with sector tilts that mirror current U.S. growth drivers.
From a macro perspective, GSUS performance is closely tied to the health of U.S. consumer spending and the Federal Reserve’s monetary stance. A sustained low-interest-rate environment tends to boost equity valuations, especially in growth-oriented sectors like tech, while any tightening could pressure the fund’s large-cap bias.
If you want a deeper, data-driven look at GSUS’s valuation metrics and how they compare across peers, consider checking out ValueRay’s analytical platform for further insight.
What is the price of GSUS shares?
Over the past week, the price has changed by -0.31%, over one month by -0.54%, over three months by +2.72% and over the past year by +14.81%.
Is GSUS a buy, sell or hold?
What are the forecasts/targets for the GSUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 112.2 | 17.9% |
GSUS Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.04b USD (3.04b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.04b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.04b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.48% (E(3.04b)/V(3.04b) * Re(9.48%) + (debt-free company))
Discount Rate = 9.48% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)